Pilatus Capital

pilatus.capital

VCMatch tracks Pilatus Capital as an investor focused on Vertical SaaS, Biotech, and Medtech companies, Pre-Seed and Seed rounds, United States, Europe, and Asia Pacific markets, and $1m to $3m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$1m to $3m

Stages

Pre-Seed, Seed, Series A

Focus Areas

Vertical SaaS, Biotech, Medtech

Geography

United States, Europe, and Asia-Pacific

Investment Thesis

Pilatus is a technology-first, research‑informed venture fund that partners with early-stage companies to develop, protect, and commercialize high-impact technologies with global reach. The firm is anchored in David Teece’s innovation-value capture model and Dynamic Capabilities framework, and emphasizes long-term value creation by focusing on transformative technology, protectable IP, and markets where innovations can set industry standards.

Is Pilatus Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Pilatus Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Vertical SaaS, Biotech, Medtech, and Digital Health, especially across United States, Europe, and Asia-Pacific, with public check-size signals around $1m to $3m.

Focus statement

Pilatus targets early-stage companies (initial commitments of $1–3 million) developing transformative, protectable technologies across Life Sciences, Clean/Advanced Energy, Transportation/Energy Management, and Retail Tech (e‑commerce, in‑store retail tech, supply chain & logistics). They primarily invest in privately-held U.S. companies but will also invest in Europe and Asia‑Pacific, and prefer to lead initial and follow‑on rounds.

Value Add

Anchored in the innovation-value capture model developed by co-founder David Teece (research-driven, academic foundation).
Operates as a 'Super Angel' investor: "leveraging our network, operational expertise, and growth management experience" to actively support portfolio companies.
Technology-first investment approach: "Our investment approach centers on the technology above all."
Focus on investible characteristics: "large addressable markets, high barriers to entry, and with the potential for setting standards across the industry."
Capital and governance discipline: "We take favorable and often significant positions but focus on acceptable valuations, capital protection, and enterprise stewardship."
Stage and ticket discipline: explicit target "initial commitments of $1-3 million" and preference to lead investments and follow‑ons.